4/15
07:01 am
sln
Form 6-K Silence Therapeutics For: Apr 15
High
Report
Form 6-K Silence Therapeutics For: Apr 15
3/27
05:08 pm
sln
Form SC 13D/A Silence Therapeutics Filed by: Griffiths Richard Ian
Low
Report
Form SC 13D/A Silence Therapeutics Filed by: Griffiths Richard Ian
3/13
08:53 am
sln
Form 20-F Silence Therapeutics For: Dec 31
Medium
Report
Form 20-F Silence Therapeutics For: Dec 31
3/13
07:11 am
sln
Form 6-K Silence Therapeutics For: Mar 13
High
Report
Form 6-K Silence Therapeutics For: Mar 13
2/23
08:12 am
sln
Form 6-K Silence Therapeutics For: Feb 23
Low
Report
Form 6-K Silence Therapeutics For: Feb 23
2/14
09:54 am
sln
Form SC 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Low
Report
Form SC 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
2/14
08:55 am
sln
Form SC 13G/A Silence Therapeutics Filed by: Deep Track Capital, LP
Low
Report
Form SC 13G/A Silence Therapeutics Filed by: Deep Track Capital, LP
2/12
06:16 pm
sln
Form SC 13G/A Silence Therapeutics Filed by: GOLDMAN SACHS GROUP INC
Low
Report
Form SC 13G/A Silence Therapeutics Filed by: GOLDMAN SACHS GROUP INC
2/9
05:05 pm
sln
Form SC 13G/A Silence Therapeutics Filed by: Artal International S.C.A.
Medium
Report
Form SC 13G/A Silence Therapeutics Filed by: Artal International S.C.A.
2/6
06:01 am
sln
Form 6-K Silence Therapeutics For: Feb 05
Low
Report
Form 6-K Silence Therapeutics For: Feb 05